C-Myc Gene Rearrangement
1 clinical trials · Condition
◉ Watch C-Myc Gene Rearrangement
| Record | Firm | Date |
|---|---|---|
| Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma (NCT05263583) | Cothera Bioscience, Inc | 2022-12-09 |
Track C-Myc Gene Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.